Case Control Study
Copyright ©The Author(s) 2022.
World J Clin Cases. May 26, 2022; 10(15): 4785-4798
Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.4785
Table 1 Comparison of pre-pandemic and pandemic groups in terms of categorical variables
Variables
Pre-pandemic, n = 61
Pandemic, n = 48
Total, n = 109
P value
Sex (%)0.629
Male53 (86.9)44 (91.7)97 (89)
Female8 (13.1)4 (8.312 (11)
LT type0.017
LDLT54 (88.5)48 (100)102 (93.6)
DDLT7 (11.5)0 (0)7 (6.4)
Child score0.353
A22 (36.1)12 (25.0)34 (31.2)
B27 (44.3)22 (45.8)49 (45.0)
C 12 (19.7)14 (29.2)26 (23.8)
Milan criteria0.337
Within36 (59.0)23 (47.9)59 (54.1)
Beyond25 (41.0)25 (52.1)50 (45.9)
UCSF criteria0.450
Within41 (67.2)28 (58.369 (63.3)
Beyond20 (32.8)20 (41.7)40 (36.7)
BCLC criteria0.429
Within46 (75.4)32 (66.7)78 (71.6)
Beyond15 (24.6)16 (33.3)31 (28.4)
Tokyo (5-5 rule)0.684
Within44 (72.1)32 (66.7)76 (69.7)
Beyond17 (27.9)16 (33.3)33 (30.3)
Onaca criteria0.293
Within45 (73.8)30 (62.5)75 (68.8)
Beyond16 (26.2)18 (37.5)34 (31.2)
CUN navara criteria0.450
Within41 (67.2)28 (58.3)69 (63.3)
Beyond20 (32.8)20 (41.7)40 (36.7)
Up-to-7 criteria0.142
Within46 (75.4)29 (60.4)75 (68.8)
Beyond15 (24.6)19 (39.434 (31.2)
AFP model0.202
Within45 (73.8)29 (60.4)74 (67.9)
Beyond16 (26.2)19 (39.6)35 (32.1)
AFP-TTD criteria0.223
Within47 (77.0)31 (64.6)78 (71.6)
Beyond14 (23.0)17 (35.4)31 (28.4)
Expanded Malatya criteria0.826
Within43 (70.5)32 (66.7)75 (68.8)
Beyond18 (29.5)16 (33.3)34 (31.2)
5-5-500 rule0.449
Within43 (70.5)30 (62.5)73 (67.0)
Beyond18 (29.5)18 (37.5)36 (33.0)
Samsung criteria0.229
Within47 (77.0)32 (66.7)79 (72.5)
Beyond14 (23.0)16 (33.330 (27.5)
Macrovascular invasion0.284
Present7 (11.5)10 (20.8)17 (15.6)
Absent54 (88.5)38 (79.2)92 (84.4)
Tumor differentiation0.066
Well31 (50.8)20 (41.7)51 (46.8)
Moderate23 (37.7)14 (29.2)37 (33.9)
Poor7 (11.5)14 (29.2)21 (19.3)
Lympho-vascular invasion0.019
Present20 (32.8)26 (55.3)46 (42.6)
Absent41 (67.2)21 (44.7)62 (57.4)
Perineural invasion0.435
Present0 (0.0)1 (2.1)1 (0.9)
Absent61 (100)46 (97.9)108 (98.2)
Capsular inasion0.651
Present2 (3.3)3 (6.4)5 (4.6)
Absent59 (96.7)44 (93.6)103 (94.5)
Tumor necrosis0.526
Present16 (26.2)9 (19.1)25 (22.9)
Absent45 (73.8)38 (80.9)83 (76.1)
Locoregional therapy ascites1.000
Yes16 (26.2)12 (25.0)28 (25.7)
No45 (73.8)36 (75.0)81 (74.3)
Ascites0.113
Mild32 (52.5)25 (52.1)57 (52.3)
Moderate22 (36.1)11 (22.9)33 (30.3)
Massive7 (11.5)12 (25.0)19 (17.4)
Outcome0.953
Alive52 (85.2)42 (87.5)94 (86.2)
Dead9 (14.8)6 (12.5)15 (13.8)
Recurrence0.693
Yes4 (6.6)2 (4.2)6 (5.5)
No57 (93.4)46 (95.8)103 (64.5)